{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:57:25Z","timestamp":1788389845345,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010937","name":"St. John's University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.colsurfb.2025.115058","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T16:26:32Z","timestamp":1755620792000},"page":"115058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P2","title":["Idasanutlin-ionizable lipid nanocomplex for enhanced solubility, stability, and anticancer activity in p53 sensitive lung cancer"],"prefix":"10.1016","volume":"256","author":[{"given":"Bhoomi","family":"Dholariya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhema","family":"Khairnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henis","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2025.115058_bib1","series-title":"Key Statistics for Lung Cancer","year":"2025"},{"key":"10.1016\/j.colsurfb.2025.115058_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.32471\/exp-oncology.2312-8852.vol-44-no-1.17411","article-title":"Current therapeutic strategies and challenges in nsclc treatment: a comprehensive review","volume":"44","author":"Kumar","year":"2022","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115058_bib3","article-title":"TP53 mutations in nonsmall cell lung cancer","volume":"2011","author":"Mogi","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.colsurfb.2025.115058_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5306\/wjco.v12.i4.217","article-title":"Oncogenic driver mutations in non-small cell lung cancer: past, present and future","volume":"12","author":"Chevallier","year":"2021","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115058_bib5","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ctrv.2014.10.004","article-title":"p53 as a target for the treatment of cancer","volume":"40","author":"Duffy","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.colsurfb.2025.115058_bib6","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/JTO.0000000000000584","article-title":"Inhibiting MDM2-p53 interaction suppresses tumor growth in Patient-Derived Non-Small cell lung cancer xenograft models","volume":"10","author":"Hai","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115058_bib7","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1158\/0008-5472.CAN-12-2807","article-title":"MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models","volume":"73","author":"Tovar","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.colsurfb.2025.115058_bib8","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1021\/jm400487c","article-title":"Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development","volume":"56","author":"Ding","year":"2013","journal-title":"J. Med Chem."},{"key":"10.1016\/j.colsurfb.2025.115058_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00280-019-03851-0","volume":"84","author":"Papai","year":"2019","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115058_bib10","article-title":"Endogenous lipid Carriers-Bench-to-Bedside roadblocks in production and drug loading of exosomes","volume":"16","author":"Richards","year":"2023","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.colsurfb.2025.115058_bib11","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.7150\/ijms.49801","article-title":"Application of nanotechnology in cancer diagnosis and therapy - a Mini-Review","volume":"17","author":"Jin","year":"2020","journal-title":"Int J. Med Sci."},{"key":"10.1016\/j.colsurfb.2025.115058_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12121194","article-title":"Self-Nano-Emulsifying Drug-Delivery systems: from the development to the current applications and challenges in oral drug delivery","volume":"12","author":"Buya","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2025.115058_bib13","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.colsurfb.2025.115058_bib14","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1021\/acs.molpharmaceut.2c01118","article-title":"Investigating key molecular descriptors affecting particle size: a predictive exemplary approach for Self-Emulsifying system","volume":"20","author":"Daware","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115058_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102292","article-title":"Novel gene therapy for drug-resistant melanoma: synergistic combination of PTEN plasmid and BRD4 PROTAC-loaded lipid nanocarriers","volume":"35","author":"Saraswat","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.colsurfb.2025.115058_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1208\/s12249-024-02978-5","article-title":"Albumin and Polysorbate-80 coated sterile nanosuspensions of mebendazole for glioblastoma therapy","volume":"25","author":"Patel","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.colsurfb.2025.115058_bib17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/03639045.2018.1546311","article-title":"Development of a solid supersaturated self-nanoemulsifying preconcentrate (S-superSNEP) of fenofibrate using dimethylacetamide and a novel co-processed excipient","volume":"45","author":"Patki","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115058_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16152713","article-title":"Synergistic efficacy of CDK4\/6 inhibitor abemaciclib and HDAC inhibitor panobinostat in pancreatic cancer cells","volume":"16","author":"Bhutkar","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.colsurfb.2025.115058_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15010182","article-title":"Palmitoyl Carnitine-Anchored nanoliposomes for Neovasculature-Specific delivery of gemcitabine elaidate to treat pancreatic cancer","volume":"15","author":"Patel","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.colsurfb.2025.115058_bib20","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1039\/C9NA00308H","article-title":"'Homme, hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers","volume":"1","author":"Ristroph","year":"2019","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.colsurfb.2025.115058_bib21","first-page":"233","article-title":"Characterization of acquired nutlin-3 resistant non-small cell lung cancer cells","volume":"4","author":"Deben","year":"2021","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.colsurfb.2025.115058_bib22","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1007\/s13277-015-3208-6","article-title":"Association of p53 and mdm2 in the development and progression of non-small cell lung cancer","volume":"36","author":"Javid","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.colsurfb.2025.115058_bib23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12935-019-0937-4","article-title":"The role of MDM2 amplification and overexpression in therapeutic resistance of malignant tumors","volume":"19","author":"Hou","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.colsurfb.2025.115058_bib24","doi-asserted-by":"crossref","first-page":"42108","DOI":"10.1038\/srep42108","article-title":"N,N dimethylacetamide a drug excipient that acts as bromodomain ligand for osteoporosis treatment","volume":"7","author":"Ghayor","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.colsurfb.2025.115058_bib25","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/17425247.2017.1266329","article-title":"Hydrophobic ion pairing as a strategy to improve drug encapsulation into lipid nanocarriers for the cancer treatment","volume":"14","author":"Oliveira","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.colsurfb.2025.115058_bib26","doi-asserted-by":"crossref","unstructured":"Maha A., Emad A-D, ION-PAIRED HYDROPHOBIC. DRUG DELIVERY SYSTEM A Rev. 2020.(Indian drugs).","DOI":"10.53879\/id.57.01.12071"},{"key":"10.1016\/j.colsurfb.2025.115058_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115754","article-title":"Oral lipid nanocomplex of BRD4 PROteolysis TArgeting chimera and vemurafenib for drug-resistant malignant melanoma","volume":"168","author":"Saraswat","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115058_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1208\/s12249-019-1332-0","article-title":"Erlotinib-Valproic acid liquisolid formulation: evaluating oral bioavailability and cytotoxicity in Erlotinib-Resistant Non-small cell lung cancer cells","volume":"20","author":"Patel","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.colsurfb.2025.115058_bib29","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2217\/nnm-2023-0219","article-title":"Delineating effect of headgroup and preparation method on transfection versus toxicity of DNA-loaded lipid nanocarriers","volume":"18","author":"Saraswat","year":"2023","journal-title":"Nanomed. (Lond. )"},{"key":"10.1016\/j.colsurfb.2025.115058_bib30","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3109\/10717544.2015.1124472","article-title":"Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer","volume":"23","author":"Doddapaneni","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2025.115058_bib31","doi-asserted-by":"crossref","first-page":"14721","DOI":"10.1002\/chem.202102523","article-title":"Engineered Cell-Penetrating peptides for Mitochondrion-Targeted drug delivery in cancer therapy","volume":"27","author":"Xiao","year":"2021","journal-title":"Chemistry"},{"key":"10.1016\/j.colsurfb.2025.115058_bib32","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1080\/17425247.2018.1517750","article-title":"Mitochondrial-targeted penetrating peptide delivery for cancer therapy","volume":"15","author":"Wu","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.colsurfb.2025.115058_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.585284","article-title":"Mechanisms and future of Non-Small cell lung cancer metastasis","volume":"10","author":"Zhu","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.colsurfb.2025.115058_bib34","first-page":"4399","article-title":"In vitro and in vivo study of GSK2830371 and RG7388 combination in liver adenocarcinoma","volume":"12","author":"Wu","year":"2022","journal-title":"Am. J. Cancer Res"},{"key":"10.1016\/j.colsurfb.2025.115058_bib35","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.4161\/cc.7.11.5929","article-title":"Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation","volume":"7","author":"Xia","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.colsurfb.2025.115058_bib36","doi-asserted-by":"crossref","first-page":"11788","DOI":"10.1073\/pnas.1203789109","article-title":"Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization","volume":"109","author":"Graves","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.colsurfb.2025.115058_bib37","doi-asserted-by":"crossref","first-page":"15026","DOI":"10.1038\/cddiscovery.2015.26","article-title":"The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma","volume":"1","author":"Lakoma","year":"2015","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.colsurfb.2025.115058_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fmolb.2020.00033","article-title":"Is it time to start transitioning from 2D to 3D cell culture?","volume":"7","author":"Jensen","year":"2020","journal-title":"Front Mol. Biosci."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777652500565X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777652500565X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:36:45Z","timestamp":1772822205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092777652500565X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":38,"alternative-id":["S092777652500565X"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115058","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Idasanutlin-ionizable lipid nanocomplex for enhanced solubility, stability, and anticancer activity in p53 sensitive lung cancer","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115058"}}